Dopavision Reports Successful Completion of Enrollment for MyopiaX-1 Trial - MyopiaX-1 trial to generate first clinical evidence with MyopiaX®, a novel therapeutic approach to manage myopia progression- First data readout expected in Q1/ 2024 with study completion planned...